Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00781352Phase 3Completed
Phase 3, randomised, double-blind trial of nitrous oxide (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Time to Colorectal Cancer Recurrence at 8 years. Started Nov 1998; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00781352.